期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重庆男男性行为者暴露前药物预防HIV感染接受意愿及其影响因素研究 被引量：14

Acceptability and influencing factors of pre-exposure prophylaxis among men who have sex with men in Chongqing
下载PDF
导出
摘要 目的：探讨重庆地区男男性行为者（men who have sex with men,MSM）对暴露前药物预防（pre-exposure prophylaxis,PrEP）措施用于降低人类免疫缺陷病毒（human immunodeficiency virus,HIV）感染风险的接受意愿及其影响因素。方法：采用滚雪球抽样法招募了重庆地区448名MSM,采用调查员协助下的自填问卷方式对他们进行问卷调查,了解MSM艾滋病相关知识、态度、行为特征、艾滋病预防措施的知识、态度、使用意愿、对PrEP知晓情况及接受意愿。采用单因素和多因素的Logistic回归。结果：PrEP在保证药物安全有效的前提下,重庆MSM人群的接受意愿可以达到76.2%左右。多因素Logistic回归分析结果表示：与MSM人群接受PrEP的意愿呈显著联系的因素有：月经济收入[OR：4.775,95%CI（1.274~17.895）,P=0.020 4;OR：1.945,95%CI（0.594~6.376）,P=0.271 8;OR：1.427,95%CI（0.357~5.698）,P=0.615 0]、对艾滋病感染者/病人的态度[OR：3.487,95%CI（0.759~16.021）,P=0.108 4;OR：4.646,95%CI（1.208~17.860）,P=0.025 4]、是否做过艾滋病病毒检测[OR：2.361,95%CI（1.118~4.986）,P=0.024 3]、是否认为应该在MSM人群中推广PrEP[OR：51.365,95%CI（5.184~508.960）,P=0.000 8;OR：8.985,95%CI（0.836~96.509）,P=0.069 9]、是否会建议您朋友采用PrEP[OR：30.882,95%CI（2.121~449.700）,P=0.012 1;OR：2.529,95%CI（0.167~38.315）,P=0.503 4]。结论：重庆地区MSM人群对PrEP接受意愿主要与对待艾滋病的态度和对待艾滋病预防措施的态度有关。提示应加强对MSM人群预防艾滋病的健康教育、扩大艾滋病咨询检测服务工作、加强MSM和PrEP供应商对PrEP的正确认识和宣传、通过网络途径促进MSM同伴教育和对PrEP的传播,以增加MSM人群对PrEP的接受意愿。 Objective：To investigate the acceptability of pre-exposure prophylaxis（PrEP） to prevent the transmission of human immunodeficiency virus（HIV） among men who have sex with men（MSM） in Chongqing.Methods：Totally 448 MSM were recruited by snowball sampling methods in Chongqing.Self-administered questionnaire survey was conducted among the recruited 448 MSM with assistant investigators collecting information on HIV-related knowledge,attitude and risk behaviors,HIV preventive measures-related knowledge,attitude and acceptability of and PrEP-related knowledge and acceptability.Univariate and multivariate Logistic regression were employed for statistical analysis.Results：The acceptability of PrEP among MSM in Chongqing reached 76.2% in the premise of drug safety and effectiveness.Results of multivariate Logistic regression analysis indicated that the factors significantly associated with acceptability of PrEP among MSM were：monthly income（OR：4.775,95%CI（1.274,17.895）,P=0.020 4;OR：1.945,95%CI（0.594,6.376）,P=0.271 8;OR：1.427,95%CI（0.357,5.698）,P=0.615 0）,attitudes towards HIV patients（OR：3.487,95%CI（0.759,16.021）,P=0.108 4;OR：4.646,95%CI（1.208,17.860）,P=0.025 4）,detection of HIV（OR：2.361,95%CI（1.118,4.986）,P=0.024 3）,PrEP promotion among MSM（OR：51.365,95% CI（5.184,508.960）,P = 0.000 8;OR：8.985,95%CI（0.836,96.509）,P=0.069 9）,advising friends to use PrEP（OR：30.882,95%CI（2.121,449.700）,P= 0.012 1;OR：2.529,95%CI（0.167,38.315）,P=0.503 4）.Conclusions：Acceptability of PrEP among MSM in Chongqing is mainly related with attitudes towards AIDS and preventive measures for AIDS,indicating that education on HIV/AIDS prevention among MSM should be reinforced,AIDS consulting and HIV testing work should be expanded,PrEP should be further understood and propagandized among MSM and providers and peer education and propagation for PrEP among MSM via internet should be improved,thus acceptability towards PrEP could be possibly increased.
作者 钟珣 钟晓妮 彭斌 张燕 黄爱龙
机构地区 重庆医科大学公共卫生与管理学院流行病与卫生统计学教研室 重庆医科大学感染性疾病分子生物学教育部重点实验室
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第4期389-394,共6页 Journal of Chongqing Medical University
基金 国家科技重大专项资助项目(编号:2008ZX10001-016)
关键词 男男性行为者 人类免疫缺陷病毒 暴露前药物预防 接受意愿 men who have sex with men human immunodeficiency virus pre-exposure prophylaxis acceptability
分类号 R181.2 [医药卫生—流行病学]
  • 相关文献

参考文献26

  • 1中华人民共和国卫生部.中国艾滋病防治联合评估报告(2007年)[R].北京:卫生部,2007.
  • 2中华人民共和国卫生部,国务院防治艾滋病工作委员会办公室,联合国艾滋病中国专题组.中国艾滋病防治联合评估报告(2009年)[R].2009.
  • 3中国艾滋病新一轮暴发[EB/OL].http://news.xinhuanet.com/herald/2009-11/30/content一12563873.htm,2009-11-30/2011-03-30.
  • 4刘叔文,李卫华,丁训诚,姜世勃.预防HIV性传播的杀微生物剂[J].中国计划生育学杂志,2008,16(5):317-320. 被引量：12
  • 5Grant R M, Wainberg M A.Chemoprophylaxis of HIV infection: moving forward with caution[J].J Infect Dis,2006,194(7):874-876.
  • 6Myers G M,Mayer K H.Oral preexposure anti-HIV prophylaxis for high-risk U.S.population:current considerations in light of new findings [J].AIDS Patient Care STDS,2011,25(2) :63-71.
  • 7Joint United Nations Programme on HIV/AIDS.Report on the Global AIDS Epidemic 2006[M].Geneva: Switzerland, 2006.
  • 8Cohen M S,Gay C,Kashuba A D,et al.Narrative review:antiretro- viral therapy to prevent the sexual transmission of HIV-I[J].Ann Intern Med,2007,146(8) :591-601.
  • 9Kellerman S E,Hutchinson A B,Begley E B,et al.Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004[J].J Acquir Immune Defic Syndr, 2006,43 (3) : 376- 377.
  • 10Voetsch A C,Huffelfinger J D,Begley E B,et al.Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events,2005 through 2006[J].J Acquir Immune Defic Syndr, 2007,46 (3) : 378-380.

二级参考文献24

  • 1Klasse PJ, Shattock R, Moore JP. Antiretroviral Drug - Based Microbicides to Prevent HIV - 1 Sexual Transmission. Annu Rev Med, 2008, 59:455 -471.
  • 2Shattock R J, Moore JP. Inhibiting sexual transmission of HIV - 1 infection. Nat Rev Microbiol, 2003, 1 : 25 - 34.
  • 3Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat Rev Drug Discov, 2002, 1 : 977 - 985.
  • 4Hillier SL, Moench T, Shattock R, et al. In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr, 2005,39 ( 1 ) : 1 - 8.
  • 5Balzarini J, Van Damme L. Microbicide drug candidates to prevent HIV infection.Lancet, 2007, 369:787 -797.
  • 6Stone A, Jiang S. Microbicides: stopping HIV at the gate. Lancet, 2006, 368:431 -433.
  • 7van de Wijgert JH, Shattock RJ. Vaginal microbicides: moving ahead after an unexpected setback. AIDS, 2007, 21 (18) : 2369 -2376.
  • 8Veazey RS, Klasse PJ, Schader S, et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus - cell fusion. Nature, 2005, 438:99-102.
  • 9Margolis L, Shattock R. Selective transmission of CCR5 - utilizing HIV-1: the 'gatekeeper'problem resolved? Nat Rev Microbiol, 2006, 4: 312 -317.
  • 10Liu S, Lu H, Neurath AR, et al. Combination of candidate microbicides cellulose acetate 1,2 -benzenedicarboxylate and UC781 results in synergistic and complementary effects against human immunodellciency virus type 1 infection. Antimicrub Agents Chemother, 2005, 49(5) : 1830 - 1836.

共引文献25

同被引文献135

  • 1程金瑾,金鑫,汪圳,娄洁.北京MSM人群HIV传播的贝叶斯推断[J].上海大学学报（自然科学版）,2021,27(6):1138-1143. 被引量：2
  • 2Beyrer C, Baral SD, van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet, 2012,380 (9839): 367-377.
  • 3Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States.JAMA, 2008, 300(5): 520-529.
  • 4卫生部.2011年中国艾滋病疫情估计报告.2011.
  • 5Grant RM, LamaJR, Anderson PL, et al. Preexposure chemopro?phylaxis for HIV prevention in men who have sex with men.N EnglJ Med, 2010, 363(27): 2587-2599.
  • 6Grant RM, Buchbinder S, Cates W, et al. Promote HIV chemoprophylaxis research, don't prevent it. Science, 2005, 309 (5744): 2170-2171.
  • 7Garcia-LermaJG, Otten RA, Qari SH, et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir[J/OL]. PLoS Med, 2008, 5 (2): e28[2013 -06-10]. http://www.plosmedicne.org/ article/ info % 3Adoi2F I 0.1371 %2Fjournal.pmed. 0050028.
  • 8Food US. Drug Administration. FDA approves first drug for reduc?ing the risk of sexually acquired HIV infection. 2012.[2013-06- 10]. http://www .fda.gov/NewsEvents/Newsroom/PressAnnounce?ments/ucm312210.htm.
  • 9World Health Organization. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Recommendations for Use in the Context of Demonstration Projects. Geneva, Switzerland: WHO, 2012.[2013-06-10]. http:// www.who.intlhiv/pub/guidance_prep/en/index.html.
  • 10Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Geneva: UNAIDS, 2008.[2013-06-10]. http://www . unaids.orgl en! dataanalysis/knowyourepidemic/ epidemiologypublications12008reportontheglobal aidsepidemic/.

引证文献14

二级引证文献89

重庆医科大学学报
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部